Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Open-Label Trial of NeisVac-C Vaccine to Evaluate Immunological Interference With Hepatitis B, Inactivated Polio and Acellular Pertussis Vaccines in Healthy Infants

NCT00161928 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00161928
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00161928 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Open-Label Trial of NeisVac-C Vaccine to Evaluate Immunological Interference With Hepatitis B, Inactivated Polio and Acellular Pertussis Vaccines in Healthy Infants
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2002
Completion date
January 31, 2003
Enrollment
330
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

meningitis, meningococcal